Home > News > New nanoemulsion safely treats serious skin infections without systemic side effects
September 12th, 2007
New nanoemulsion safely treats serious skin infections without systemic side effects
A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.
"Results of the phase 1 clinical trial are important to the fields of dermatology and infectious diseases because currently approved systemic medications for onychomycosis carry serious risks of cardiac and liver toxicity," said James Baker, MD, chief science officer and founder of NanoBio Corporation in Ann Arbor, Mich.
Graphene rubber bands could stretch limits of current healthcare, new research finds August 19th, 2014
Interaction between Drug, DNA for Designing Anticancer Drugs Studied in Iran August 17th, 2014
Scientists fold RNA origami from a single strand: RNA origami is a new method for organizing molecules on the nanoscale. Using just a single strand of RNA, this technique can produce many complicated shapes. August 14th, 2014
Iranian Scientists Stabilize Protein on Highly Stable Electrode Surface August 14th, 2014
Сalculations with Nanoscale Smart Particles August 19th, 2014
Life on Mars? Implications of a newly discovered mineral-rich structure August 19th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Electrical engineers take major step toward photonic circuits: Team invents non-metallic metamaterial that enables them to 'compress' and contain light August 19th, 2014